Tru-cut placental site trophoblastic tumor biopsy: A novel way for diagnosis. Case report
Article Sidebar
Main Article Content
Abstract
Background: A Placental Site Trophoblastic Tumor (PSTT) is a rare form of gestational trophoblastic disease and usually manifests itself with abnormal uterine bleeding and elevated β-hCG serum levels even months or years after any antecedent pregnancy event. Typically, tumors are confined into the uterus and secrete lower levels of β-hCG compared with other Gestational Trophoblastic Neoplasia (GTN). They can be detected sonographically like heterogeneous solid mass in the uterine cavity with minimal to high vascularization, but sometimes they develop into myometrium without endometrial involvement. To the best of our knowledge, uterine biopsy is the only way to make a reliable diagnosis, but for these reasons sometimes Dilation and Curettage (D&C) or hysteroscopy are not exhaustive. Their final diagnosis is histopathological and often very difficult due to their rarity, thus many times they directly present metastasis symptoms (mainly pulmonary) or paraneoplastic syndromes.
Case presentation: A 37-year-old woman with the purpose of a second pregnancy, after seven weeks of amenorrhea, complained irregular bleeding and metrorrhagia. The patient underwent transvaginal ultrasound (US) and a lesion of 50 mm was found in myometrium, its echostructure was inhomogeneous and richly vascularised (CS4) with rear acoustic reinforcement. It was associated with slightly elevated serum levels of β-hCG. The patient performed a hysteroscopy with simultaneous tru-cut biopsy of the lesion under US guidance and a placental site trophoblastic tumor was diagnosed by histological examination.
Conclusion: In this paper we suggest a novel method to perform the PSTT diagnosis. A tru-cut core biopsy allows a deep and precise biopsy with less invasivity and low risk of bleeding or uterine damage. Our case study shows that the employment of this novel technique can help in the diagnosis through a targeted sampling of the myometrium even in those cases in which the endometrial cavity is not involved.
Downloads
Article Details
Copyright (c) 2023 Sirito R, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Burkett WC, Soper JT. A Review of Current Management of Placental Site Trophoblastic Tumor and Epithelioid Trophoblastic Tumor. Obstet Gynecol Surv. 2022 Feb;77(2):101-110. doi: 10.1097/OGX.0000000000000978. PMID: 35201361.
Zhou Y, Lu H, Yu C, Tian Q, Lu W. Sonographic characteristics of placental site trophoblastic tumor. Ultrasound Obstet Gynecol. 2013 Jun;41(6):679-84. doi: 10.1002/uog.12269. PMID: 22807194.
Alexander AL, Strohl AE, Maniar KP, Lurain JR. Placental site trophoblastic tumor: Successful treatment of 13 cases. Gynecol Oncol Rep. 2020 Feb 13;32:100548. doi: 10.1016/j.gore.2020.100548. PMID: 32274412; PMCID: PMC7132153.
Chang YL, Chang TC, Hsueh S, Huang KG, Wang PN, Liu HP, Soong YK. Prognostic factors and treatment for placental site trophoblastic tumor-report of 3 cases and analysis of 88 cases. Gynecol Oncol. 1999 May;73(2):216-22. doi: 10.1006/gyno.1999.5344. PMID: 10329037.
Zhang X, Zhou C, Yu M, Chen X. Coexisting epithelioid trophoblastic tumor and placental site trophoblastic tumor of the uterus following a term pregnancy: report of a case and review of literature. Int J Clin Exp Pathol. 2015 Jun 1;8(6):7254-9. PMID: 26261623; PMCID: PMC4525957.
De Nola R, Schönauer LM, Fiore MG, Loverro M, Carriero C, Di Naro E. Management of placental site trophoblastic tumor: Two case reports. Medicine (Baltimore). 2018 Nov;97(48):e13439. doi: 10.1097/MD.0000000000013439. PMID: 30508960; PMCID: PMC6283185.
Nagamine K, Iwasaki S, Shimizu D, Tauchi-Nishi P, Terada K. Placental site trophoblastic tumor with sole metastasis to breast: A case report. Gynecol Oncol Rep. 2017 Jul 12;21:86-90. doi: 10.1016/j.gore.2017.07.003. PMID: 28795129; PMCID: PMC5537104.
Nguyen Ba E, Golfier F, Malhaire C, Louafi L, Alran S. Tumeur du site d’implantation trophoblastique : quand la suspecter et quel traitement décider ? [Placental site trophoblastic tumor: When do we suspect it and which treatment shall we decide?]. J Gynecol Obstet Biol Reprod (Paris). 2016 Oct;45(8):979-984. French. doi: 10.1016/j.jgyn.2016.04.003. Epub 2016 Sep 28. PMID: 27692520.
Sato W, Miura Y, Shirasawa H, Kumazawa Y, Kumagai J, Terada Y. A case of placental site trophoblastic tumor complicating nephrotic syndrome in which hysteroscopic biopsy did not yield a definitive diagnosis. Gynecol Minim Invasive Ther. 2017 Apr-Jun;6(2):69-72. doi: 10.1016/j.gmit.2016.11.006. Epub 2017 Jan 4. PMID: 30254879; PMCID: PMC6113977.
Behnamfar F, Mousavi A, Rezapourian P, Zamani A. Placental site trophoblastic tumor, report of a case with unusual presentation. Placenta. 2013 May;34(5):460-2. doi: 10.1016/j.placenta.2013.01.010. Epub 2013 Mar 9. PMID: 23478075.